Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP266847.RATDRT1MeQxUb9WCz-7-d_NWxAbPpbTwyXre5lqWGO3PU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP266847.RATDRT1MeQxUb9WCz-7-d_NWxAbPpbTwyXre5lqWGO3PU130_assertion type Assertion NP266847.RATDRT1MeQxUb9WCz-7-d_NWxAbPpbTwyXre5lqWGO3PU130_head.
- NP266847.RATDRT1MeQxUb9WCz-7-d_NWxAbPpbTwyXre5lqWGO3PU130_assertion description "[The proliferation index assessed by using Ki-67 (MIB1) was 5% in the low-grade B-cell lymphoma, 80% in the plasmablastic myeloma, 90-95% in three cases of diffuse large B-cell lymphoma, and ranged from 90 to >99% in most Burkitt and atypical Burkitt neoplasms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP266847.RATDRT1MeQxUb9WCz-7-d_NWxAbPpbTwyXre5lqWGO3PU130_provenance.
- NP266847.RATDRT1MeQxUb9WCz-7-d_NWxAbPpbTwyXre5lqWGO3PU130_assertion evidence source_evidence_literature NP266847.RATDRT1MeQxUb9WCz-7-d_NWxAbPpbTwyXre5lqWGO3PU130_provenance.
- NP266847.RATDRT1MeQxUb9WCz-7-d_NWxAbPpbTwyXre5lqWGO3PU130_assertion SIO_000772 16258503 NP266847.RATDRT1MeQxUb9WCz-7-d_NWxAbPpbTwyXre5lqWGO3PU130_provenance.
- NP266847.RATDRT1MeQxUb9WCz-7-d_NWxAbPpbTwyXre5lqWGO3PU130_assertion wasDerivedFrom befree-20140225 NP266847.RATDRT1MeQxUb9WCz-7-d_NWxAbPpbTwyXre5lqWGO3PU130_provenance.
- NP266847.RATDRT1MeQxUb9WCz-7-d_NWxAbPpbTwyXre5lqWGO3PU130_assertion wasGeneratedBy ECO_0000203 NP266847.RATDRT1MeQxUb9WCz-7-d_NWxAbPpbTwyXre5lqWGO3PU130_provenance.